title: Microangiopathic Hemolytic Anemia Associated with the use of both Cyclosporin A and FK506 (Tacrolimus) in the Same Patient.
abstract: Microangiopathic hemolytic anemia (MAHA) is a well recognized complication of cyclosporin A (CyA) immunosupressive therapy post bone marrow and solid organ transplant but has rarely been reported in association with FK506 (tacrolimus), we describe a unique patient in whom both CyA and FK506 appear to have caused microangiopathy following an allogeneic peripheral stem cell transplant.
authors.affiliation: a Department of Haematology , Leicester Royal Infirmary , Leicester , UK.
authors.forename: P T
authors.initials: PT
authors.lastname: Murphy
authors.affiliation: b Department of Integrated Medicine , Queen Elizabeth Hospital , Birmingham , UK .
authors.forename: M C
authors.initials: MC
authors.lastname: Casey
authors.affiliation: a Department of Haematology , Leicester Royal Infirmary , Leicester , UK.
authors.forename: M
authors.initials: M
authors.lastname: Manachi
authors.affiliation: a Department of Haematology , Leicester Royal Infirmary , Leicester , UK.
authors.forename: R M
authors.initials: RM
authors.lastname: Hutchinson
keywords: FK506; Microangiopathic hernolytic anemia; allogeneic transplant; cyclosporin A; tacrolimus